Publikationen von Gereon Rudolf Fink

Trempler, I.; Binder, E.; Reuter, M.; Plieger, T.; Standke, I.; Mecklenbrauck, F.; Meinert, S.; Forstner, A. J.; Nothen, M. M.; Rietschel, M. et al.; Stürmer, S.; Dannlowski, U.; Tittgemeyer, M.; Lencer, R.; Fink, G. R.; Schubotz, R. I.: Effects of DRD2/ANKK1 and COMT Val158Met polymorphisms on stabilization against and adaptation to unexpected events. Cerebral Cortex (angenommen)

Richter, N.; David, L.-S.; Grothe, M. J.; Teipel, S.; Dietlein, M.; Tittgemeyer, M.; Neumaier, B.; Fink, G. R.; Onur, O. A.; Kukolja, J.: Age and anterior basal forebrain volume predict the cholinergic deficit in patients with mild cognitive impairment due to Alzheimer's disease. Journal of Alzheimer's Disease: JAD 86 (1), S. 425 - 440 (2022)

Blaschke, S.; Hensel, L.; Minassian, A.; Vlachakis, S.; Tscherpel, C.; Vay, S. U.; Rabenstein, M.; Schroeter, M.; Fink, G. R.; Hoehn, M. et al.; Grefkes, C.; Rueger, M. A.: Translating functional connectivity after stroke functional magnetic resonance imaging detects comparable network changes in mice and humans. Stroke 52 (9), S. 2948 - 2960 (2021)

Jergas, H.; Grindegard, L.; Schultze, T.; Thanarajah, S. E.; Kalbe, E.; Van Eimeren, T.; Dafsari, H. S.; Dembek, T. A.; Visser-Vandewalle, V.; Fink, G. R. et al.; Timmermann, L.; Schilbach, L.; Barbe, M. T.: The impact of subthalamic deep brain stimulation on belief revision and social validation. Parkinsonism & Related Disorders 89, S. 84 - 86 (2021)

Gramespacher, H.; Richter, N.; Thanarajah, S. E.; Jacobs, H. I.L.; Dillen, K.N.H.; Nellessen, N.; von Reutern, B.; Dronse, J.; Kukolja, J.; Fink, G. R. et al.; Onur, O. A.: Aberrant frontostriatal connectivity in Alzheimer's disease with positive palmomental reflex. European Journal of Neurology 27 (12), S. 2405 - 2414 (2020)

Pelzer, E. A.; Dillenburger, B. C.; Grundmann, S.; Iliaev, V.; Aschenberg, S.; Melzer, C.; Hess, M.; Fink, G. R.; Eggers, C.; Tittgemeyer, M. et al.; Timmermann, L.: Hypomania and saccadic changes in Parkinson's disease: influence of D2 and D3 dopaminergic signalling. npj Parkinson's Disease 6 (1), 5 (2020)

Hammes, J.; Theis, H.; Giehl, K.; Hoenig, M. C.; Greuel, A.; Tittgemeyer, M.; Fink, G. R.; Drzezga, A.; Eggers, C.; Van Eimeren, T.: Dopamine metabolism of the nucleus accumbens and fronto-striatal connectivity modulate impulse control. Brain 142 (3), S. 733 - 743 (2019)

Pallast, N.; Diedenhofen, M.; Blaschke, S.; Wieters, F.; Wiedermann, D.; Hoehn, M.; Fink, G. R.; Aswendt, M.: Processing pipeline for atlas-based imaging data analysis of structural and functional mouse brain MRI (AIDAmri). Frontiers in Neuroinformatics 13, 42 (2019)

Rabenstein, M.; Unverricht-Yeboah, M.; Keuters, M. H.; Pikhovych, A.; Hucklenbroich, J.; Vay, S. U.; Blaschke, S.; Ladwig, A.; Walter, H. L.; Beiderbeck, M. et al.; Fink, G. R.; Schroeter, M.; Kriehuber, R.; Rueger, M. A.: Transcranial current stimulation alters the expression of immune-mediating genes. Frontiers in Cellular Neuroscience 13, 461 (2019)

Richter, N.; Nellessen, N.; Dronse, J.; Dillen, K.; Jacobs, H. I.L.; Langen, K.-J.; Dietlein, M.; Kracht, L.; Neumaier, B.; Fink, G. R. et al.; Kukolja, J.; Onur, O. A.: Spatial distributions of cholinergic impairment and neuronal hypometabolism differ in MCI due to AD. NeuroImage: Clinical 24, 101978 (2019)

Thanarajah, S. E.; Prüss, H.; Warnke, C.; Barbe, M. T.; Schroeter, M.; Fink, G. R.; Onur, O. A.: Atypical autoimmune encephalitis with neuropil antibodies against a yet unknown epitope. Frontiers in Neurology 10, 175 (2019)

Hagelweide, K.; Schönberger, A. R.; Kracht, L. W.; Gründler, T. O. J.; Fink, G. R.; Schubotz, R. I.: Motor cognition in patients treated with subthalamic nucleus deep brain stimulation: Limits of compensatory overactivity in Parkinson's disease. Neuropsychologia 117, S. 491 - 499 (2018)

Michely, J.; Volz, L. J.; Hoffstaedter, F.; Tittgemeyer, M.; Eickhoff, S. B.; Fink, G. R.; Grefkes, C.: Network connectivity of motor control in the ageing brain. NeuroImage: Clinical 18, S. 443 - 455 (2018)

Richter, N.; Beckers, N.; Onur, O. A.; Dietlein, M.; Tittgemeyer, M.; Kracht, L. W.; Neumaier, B.; Fink, G. R.; Kukolja, J.: Effect of cholinergic treatment depends on cholinergic integrity in early Alzheimer's disease. Brain 141 (3), S. 903 - 915 (2018)

Rogall, R.; Rabenstein, M.; Vay, S.; Bach, A.; Pikhovych, A.; Baermann, J.; Höhn, M.; Couillard-Després, S.; Fink, G. R.; Schroeter, M. et al.; Rueger, M. A.: Bioluminescence imaging visualizes osteopontin-induced neurogenesis and neuroblast migration in the mouse brain after stroke. Stem Cell Research and Therapy 9 (1), 182 (2018)

Diekhoff-Krebs, S.; Pool, E.-M.; Sarfeld, A.-S.; Rehme, A. K.; Eickhoff, S. B.; Fink, G. R.; Grefkes, C.: Interindividual differences in motor network connectivity and behavioral response to iTBS in stroke patients. NeuroImage: Clinical 15, S. 559 - 571 (2017)

Richter, N.; Michel, A.; Onur, O. A.; Kracht, L. W.; Dietlein, M.; Tittgemeyer, M.; Fink, G. R.; Kukolja, J.: White matter lesions and the cholinergic deficit in aging and mild cognitive impairment. Neurobiology of Aging 53, S. 27 - 35 (2017)

Backes, H.; Walberer, M. I.; Ladwig, A.; Rueger, M. A.; Neumaier, B.; Endepols, H.; Höhn, M.; Fink, G. R.; Schroeter, M.; Graf, R.: Glucose consumption of inflammatory cells masks metabolic deficits in the brain. NeuroImage 128, S. 54 - 62 (2016)

Braun, R.; Klein, R.; Walter, H. L.; Ohren, M.; Freudenmacher, L.; Getachew, K.; Ladwig, A.; Luelling, J.; Neumaier, B.; Endepols, H. et al.; Graf, R.; Höhn, M.; Fink, G. R.; Schroeter, M.; Rueger, M. A.: Transcranial direct current stimulation accelerates recovery of function, induces neurogenesis and recruits oligodendrocyte precursors in a rat model of stroke. Experimental Neurology 279, S. 127 - 136 (2016)

Klein, R.; Mahlberg, N.; Ohren, M.; Ladwig, A.; Neumaier, B.; Graf, R.; Höhn, M.; Albrechtsen, M.; Rees, S.; Fink, G. R. et al.; Rueger, M. A.; Schroeter, M.: The neural cell adhesion molecule-derived (NCAM)-peptide FG loop (FGL) mobilizes endogenous neural stem cells and promotes endogenous regenerative capacity after stroke. Journal of Neuroimmune Pharmacology 11 (4), S. 708 - 720 (2016)